The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middendorp, S.
Right arrow Articles by Hendriks, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middendorp, S.
Right arrow Articles by Hendriks, R. W.
The Journal of Immunology, 2004, 172: 1371-1379.
Copyright © 2004 by The American Association of Immunologists

Cellular Maturation Defects in Bruton’s Tyrosine Kinase-Deficient Immature B Cells Are Amplified by Premature B Cell Receptor Expression and Reduced by Receptor Editing1

Sabine Middendorp and Rudolf W. Hendriks2

Department of Immunology, Erasmus MC Rotterdam, Rotterdam, The Netherlands

In the mouse, Bruton’s tyrosine kinase (Btk) is essential for efficient developmental progression of CD43+CD2- large cycling into CD43-CD2+ small resting pre-B cells in the bone marrow and of IgMhigh transitional type 2 B cells into IgMlow mature B cells in the spleen. In this study, we show that the impaired induction of cell surface changes in Btk-deficient pre-B cells was still noticeable in {kappa}+ immature B cells, but was largely corrected in {lambda}+ immature B cells. As {lambda} gene rearrangements are programmed to follow {kappa} rearrangements and {lambda} expression is associated with receptor editing, we hypothesized that the transit time through the pre-B cell compartment or receptor editing may affect the extent of the cellular maturation defects in Btk-deficient B cells. To address this issue, we used 3-83µ{delta} transgenic mice, which prematurely express a complete B cell receptor and therefore manifest accelerated B cell development. In Btk-deficient 3-83µ{delta} mice, the IgM+ B cells in the bone marrow exhibited a very immature phenotype (pre-BCR+CD43+CD2-) and were arrested at the transitional type 1 B cell stage upon arrival in the spleen. However, these cellular maturation defects were largely restored when Btk-deficient 3-83µ{delta} B cells were on a centrally deleting background and therefore targeted for receptor editing. Providing an extended time window for developing B cells by enforced expression of the antiapoptotic gene Bcl-2 did not alter the Btk dependence of their cellular maturation. We conclude that premature B cell receptor expression amplifies the cellular maturation defects in Btk-deficient B cells, while extensive receptor editing reduces these defects.


Related articles in The JI:

IN THIS ISSUE

The JI 2004 172: 1331-1332. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Verkoczy, B. Duong, P. Skog, D. Ait-Azzouzene, K. Puri, J. L. Vela, and D. Nemazee
Basal B Cell Receptor-Directed Phosphatidylinositol 3-Kinase Signaling Turns Off RAGs and Promotes B Cell-Positive Selection
J. Immunol., May 15, 2007; 178(10): 6332 - 6341.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. S. M. Rahman and T. Manser
B Cells Expressing Bcl-2 and a Signaling-Impaired BAFF-Specific Receptor Fail to Mature and Are Deficient in the Formation of Lymphoid Follicles and Germinal Centers
J. Immunol., November 15, 2004; 173(10): 6179 - 6188.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y.-S. Ng, H. Wardemann, J. Chelnis, C. Cunningham-Rundles, and E. Meffre
Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
J. Exp. Med., October 4, 2004; 200(7): 927 - 934.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.